1. Home
  2. SPRC vs OGEN Comparison

SPRC vs OGEN Comparison

Compare SPRC & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • OGEN
  • Stock Information
  • Founded
  • SPRC 2004
  • OGEN 1996
  • Country
  • SPRC Israel
  • OGEN United States
  • Employees
  • SPRC 3
  • OGEN 5
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • OGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPRC Health Care
  • OGEN Health Care
  • Exchange
  • SPRC Nasdaq
  • OGEN Nasdaq
  • Market Cap
  • SPRC 4.8M
  • OGEN 3.9M
  • IPO Year
  • SPRC N/A
  • OGEN N/A
  • Fundamental
  • Price
  • SPRC $0.45
  • OGEN $0.29
  • Analyst Decision
  • SPRC
  • OGEN
  • Analyst Count
  • SPRC 0
  • OGEN 0
  • Target Price
  • SPRC N/A
  • OGEN N/A
  • AVG Volume (30 Days)
  • SPRC 837.4K
  • OGEN 14.3M
  • Earning Date
  • SPRC 02-15-2025
  • OGEN 03-28-2025
  • Dividend Yield
  • SPRC N/A
  • OGEN N/A
  • EPS Growth
  • SPRC N/A
  • OGEN N/A
  • EPS
  • SPRC N/A
  • OGEN N/A
  • Revenue
  • SPRC $1,747,000.00
  • OGEN N/A
  • Revenue This Year
  • SPRC N/A
  • OGEN N/A
  • Revenue Next Year
  • SPRC N/A
  • OGEN N/A
  • P/E Ratio
  • SPRC N/A
  • OGEN N/A
  • Revenue Growth
  • SPRC N/A
  • OGEN N/A
  • 52 Week Low
  • SPRC $0.20
  • OGEN $0.25
  • 52 Week High
  • SPRC $4.29
  • OGEN $3.47
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 43.71
  • OGEN 46.16
  • Support Level
  • SPRC $0.43
  • OGEN $0.28
  • Resistance Level
  • SPRC $0.55
  • OGEN $0.31
  • Average True Range (ATR)
  • SPRC 0.06
  • OGEN 0.05
  • MACD
  • SPRC -0.01
  • OGEN 0.00
  • Stochastic Oscillator
  • SPRC 25.84
  • OGEN 9.39

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.

Share on Social Networks: